Workman v. Kretzer

District Court, D. Kansas·Decided February 4, 2022·No. 2:20-cv-02605·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF KANSAS

ANGELA WORKMAN, ) individually and as personal representative of ) the Estate of Paul Workman, ) ) Plaintiff, ) ) v. ) Case No. 20-2605-JWL ) CHRISTOPHER KRETZER and ) MARTEN TRANSPORT, LTD., ) ) Defendants. ) ) _______________________________________)

MEMORANDUM AND ORDER

This wrongful death action presently comes before the Court on the parties’ motions to exclude certain expert testimony. By her motion (Doc. # 58), plaintiff seeks to exclude certain testimony by defendants’ experts Sarah Urfer and Gray Beauchamp. As more fully set forth below, this motion is granted in part and denied in part. By their motions (Doc. ## 59, 63), defendants seek to exclude certain testimony by plaintiff’s expert Brooke Liggett. For the reasons set forth below, defendants’ motions are hereby denied.

I. Governing Standards In Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court instructed that district courts are to perform a “gatekeeping” role concerning the admission of expert testimony. See id. at 589-93; see also Kumho Tire Co. Ltd. v. Carmichael, 526 U.S. 137, 147-48 (1999). The admissibility of expert testimony is governed by Rule 702 of the Federal Rules of Evidence, which states: A witness who is qualified as an expert by knowledge, skill, experience, training, or education may testify in the form of an opinion or otherwise if: (a) the expert's scientific, technical, or other specialized knowledge will help the trier of fact to understand the evidence or to determine a fact in issue; (b) the testimony is based on sufficient facts or data; (c) the testimony is the product of reliable principles and methods; and (d) the expert has reliably applied the principles and methods to the facts of the case. See Fed. R. Evid. 702. In order to determine that an expert’s opinions are admissible, this Court must undertake a two-part analysis: first, the Court must determine that the witness is qualified by “knowledge, skill, experience, training, or education” to render the opinions; and

second, the Court must determine whether the witness’s opinions are “reliable” under the principles set forth in Daubert and Kumho Tire. See Ralston v. Smith & Nephew Richards, Inc., 275 F.3d 965, 969 (10th Cir. 2001). The rejection of expert testimony is the exception rather than the rule. See Fed. R. Evid. 702 advisory committee notes. Nevertheless, “[t]he proponent of expert testimony bears the burden of showing that its proffered expert’s

testimony is admissible.” See United States v. Nacchio, 555 F.3d 1234, 1241 (10th Cir. 2009). In Daubert the Supreme Court listed four factors relevant to assessing reliability: (1) whether the theory has been tested; (2) whether the theory has been subject to peer review and publication; (3) the known or potential rate of error associated with the theory; and (4) whether the theory has attained widespread or general acceptance. See Daubert, 509 U.S. at 592-94. In Kumho Tire, however, the Supreme Court emphasized that these

four factors are not a “definitive checklist or test” and that a court=s inquiry into reliability must be “tied to the facts of a particular case.” See Kumho Tire, 526 U.S. at 150. In some cases, “the relevant reliability concerns may focus upon personal knowledge or experience,” rather than the Daubert factors and scientific foundations. See id. (quoted in Bitler v. A.O. Smith Corp., 400 F.3d 1227, 1235 (10th Cir. 2004)). The district court has

“considerable leeway in deciding in a particular case how to go about determining whether particular expert testimony is reliable.” See Kumho Tire, 526 U.S. at 152.

II. Plaintiff’s Motion to Exclude A. Testimony by Sarah Urfer

Defendants have designated Sarah Urfer, a forensic toxicologist, as a retained expert in this case. In her report Ms. Urfer discussed the results of laboratory tests of decedent’s blood obtained during an autopsy performed six days after the accident. Ms. Urfer noted that the tests showed particular concentrations of three drugs: amphetamine, commonly known as Aderall, a central nervous system (CNS) stimulant; phentermine, a CNS

stimulant; and alprazolam, commonly known as Xanax, a CNS depressant. Ms. Urfer discussed these drugs’ therapeutic ranges and the effects of taking them (even within those therapeutic ranges), including the effects of taking them together, and including the effects on one operating a vehicle. Ms. Urfer concluded as follows: It is my professional opinion that, in general, I would expect this combination of amphetamine, phentermine, and alprazolam to cause substantial impairment. Mr. Workman's inability to avoid the collision with Mr. Kretzer's semi-trailer is consistent with the toxicology results and the impairment I would expect. Prescription medications can be impairing even when taking as prescribed by a doctor, and that impairment can become more pronounced when taken with other medications that effect [sic] the central nervous system. While Mr. Workman did possess a prescription for both d- amphetamine and alprazolam, alprazolam can be impairing even within the therapeutic range. The level of amphetamine detected in Mr. Workman's blood at the time of the autopsy was nearly six times greater than the maximum therapeutic range and is inconsistent with Mr. Workman having taken a single 30 mg dose as prescribed. Therefore, it is my professional opinion that a person such as Mr. Workman would be substantially incapable of properly and safely operating a motor vehicle at the time of the crash while under the influence of these drugs as described. In seeking to exclude certain expert opinions, plaintiff does not object to Ms. Urfer’s qualifications. Rather, plaintiff argues that the opinions do not satisfy the reliability requirement. Specifically, plaintiff argues that Ms. Urfer’s opinions based on a quantitative analysis of decedent’s blood should be excluded as unreliable because the blood was drawn from decedent’s chest cavity and not from another location as recommended, with the result that the findings were likely tainted by post-mortem redistribution (PMR) of the drugs in decedent’s system. Ms. Urfer agreed in her deposition that taking blood from the femoral or iliac vessels is ideal if such blood is available. She also testified that PMR primarily becomes an issue in the case of an unrefrigerated body, but that while refrigeration slows PMR and decreases the likelihood of issues, it does not prevent PMR altogether. Ms. Urfer did not dispute that PMR is always a possibility, and she testified that she was unable to assess whether and to what extent PMR occurred with respect to decedent because she had no means (such as a second blood draw from another location) by which to make such assessment, although she saw no indication of elevated results from PMR in this case. When asked for an authoritative source stating that a quantitative analysis could be reliably performed on a

Free access — add to your briefcase to read the full text and ask questions with AI

Workman v. Kretzer, (D. Kan. 2022).

Workman v. Kretzer (Workman v. Kretzer) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Daubert v. Merrell Dow Pharmaceuticals, Inc.
509 U.S. 579 (Supreme Court, 1993)
Kumho Tire Co. v. Carmichael
526 U.S. 137 (Supreme Court, 1999)
Ralston v. Smith & Nephew Richards, Inc.
275 F.3d 965 (Tenth Circuit, 2001)
Bitler v. A.O. Smith Corp.
400 F.3d 1227 (Tenth Circuit, 2004)
United States v. Nacchio
555 F.3d 1234 (Tenth Circuit, 2009)
Cochrane v. Schneider National Carriers, Inc.
980 F. Supp. 374 (D. Kansas, 1997)